Literature DB >> 23166114

New therapeutic pathways in the RAS.

Michael Bader1, Robson A Santos, Thomas Unger, U Muscha Steckelings.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23166114     DOI: 10.1177/1470320312466519

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


× No keyword cloud information.
  13 in total

Review 1.  Rewinding sarcopenia: a narrative review on the renin-angiotensin system.

Authors:  Timur Ekiz; Murat Kara; Ayşe Merve Ata; Vincenzo Ricci; Özgür Kara; Fırat Özcan; Levent Özçakar
Journal:  Aging Clin Exp Res       Date:  2021-01-04       Impact factor: 3.636

Review 2.  New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?

Authors:  Anna Gromotowicz-Poplawska; Piotr Szoka; Patrycjusz Kolodziejczyk; Karol Kramkowski; Marzena Wojewodzka-Zelezniakowicz; Ewa Chabielska
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-19

3.  Dose-dependent, therapeutic potential of angiotensin-(1-7) for the treatment of pulmonary arterial hypertension.

Authors:  Siegfried Breitling; Adrienn Krauszman; Richa Parihar; Thomas Walther; Mark K Friedberg; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

4.  Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling.

Authors:  Anna M Papinska; Maira Soto; Christopher J Meeks; Kathleen E Rodgers
Journal:  Pharmacol Res       Date:  2016-03-05       Impact factor: 7.658

Review 5.  G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?

Authors:  Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Front Pharmacol       Date:  2015-02-17       Impact factor: 5.810

Review 6.  New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?

Authors:  Ludovit Paulis; Romana Rajkovicova; Fedor Simko
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

7.  Modulation of angiotensin II signaling in the prevention of fibrosis.

Authors:  Amanda M Murphy; Alison L Wong; Michael Bezuhly
Journal:  Fibrogenesis Tissue Repair       Date:  2015-04-23

8.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

9.  ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

Authors:  Cecilia Riquelme; María José Acuña; Javiera Torrejón; Daniela Rebolledo; Daniel Cabrera; Robson A Santos; Enrique Brandan
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

Review 10.  Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure.

Authors:  Leon A Danyel; Patrick Schmerler; Ludovit Paulis; Thomas Unger; U Muscha Steckelings
Journal:  Integr Blood Press Control       Date:  2013-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.